To this end, we compared expression of hPL mRNA and protein in breast cancer cell lines (BCC), normal breast tissue, primary breast tumors, and choriocarcinoma cell lines, using complementary approaches that include conventional and real-time PCR, western blotting, IHC, overexpression and knockdown. The gene discussed is LGALS1; the disease is breast carcinoma.